Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical Research Article
  • Published:

Early motor outcomes in infants with complex congenital heart disease: the predictive role of NSE and S100B

Abstract

Background

Children with complex congenital heart disease (CCHD) are at high risk for early neurodevelopmental delays across all domains. Neuromotor delay often emerges first and may impact broader development. Identifying early biomarkers of motor function could capture a critical window for intervention. We assessed the prognostic value of neuron-specific enolase (NSE) and S100B in predicting 4-month motor outcomes in newborns undergoing cardiac surgery with cardiopulmonary bypass (CPB).

Methods

Between December 2021 and October 2024, we conducted a prospective, single-centre study including term neonates with (CCHD) who required cardiac surgery within the first two months of life. NSE and S100B levels were measured at five perioperative time points. Blinded Alberta Infant Motor Scale (AIMS) assessment at four months evaluated motor outcomes.

Results

Of 35 newborns, 27 completed follow-up. Preoperative NSE levels were significantly higher in infants with AIMS scores below the 10th percentile (32.7 vs. 20.9 ng/mL, p = 0.044) and negatively correlated with AIMS percentiles (ρ = –0.617, p = 0.006. There was no significant association between motor outcomes, MRI findings or S100B levels.

Conclusions

Higher preoperative NSE levels predict poor early motor outcomes in CCHD and may be a marker for early risk stratification and intervention.

Impact

  • Neuron-specific enolase (NSE) may serve as an early biomarker of neuromotor development in newborns with complex congenital heart disease (CCHD). Elevated preoperative NSE levels were associated with poorer motor outcomes at four months. NSE may serve as an additional biomarker within a multimodal risk stratification strategy, complementing clinical, imaging, and electrophysiological assessments to refine prognostic evaluation. These findings highlight the prognostic value of perioperative biomarkers for predicting early motor outcomes and support earlier identification of at-risk newborns, enabling targeted neurodevelopmental interventions. This work adds new evidence to limited literature on biological predictors of motor development after neonatal cardiac surgery.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Four-month follow-up of newborns with CCHD operated on within the first two months of life.
Fig. 2: Evolution of NSE and S100B biomarkers over time in the total cohort and by AIMS groups.
Fig. 3: Spearman correlations between NSE and S100B levels and AIMS percentile scores.
Fig. 4: Correlation matrices between clinical variables, biomarkers, and motor outcome (AIMS percentile).

Similar content being viewed by others

Data availability

the datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Hoffman, J. I. E. & Kaplan, S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39, 1890–1900 (2002).

    Article  PubMed  Google Scholar 

  2. Limperopoulos, C. et al. Brain volume and metabolism in fetuses with congenital heart disease: evaluation with quantitative magnetic resonance imaging and spectroscopy. Circulation 121, 26 (2010).

    Article  PubMed  CAS  Google Scholar 

  3. Rollins, C. K. et al. Regional brain growth trajectories in fetuses with congenital heart disease. Ann. Neurol. 89, 143–157 (2021).

    Article  PubMed  Google Scholar 

  4. Miller, S. P. et al. Preoperative brain injury in newborns with transposition of the great arteries. Ann. Thorac. Surg. 77, 1698–1706 (2004).

    Article  PubMed  Google Scholar 

  5. Miller, S. P. et al. Abnormal brain development in newborns with congenital heart disease. N. Engl. J. Med. 357, 1928–1938 (2007).

    Article  PubMed  CAS  Google Scholar 

  6. Ehrler, M. et al. White matter microstructure and executive functions in congenital heart disease from childhood to adulthood: a pooled case-control study. Child. Neuropsychol. J. Norm. Abnorm. Dev. Child. Adolesc. 29, 1064–1087 (2023).

    Google Scholar 

  7. Long, S. H., Harris, S. R., Eldridge, B. J. & Galea, M. P. Gross motor development is delayed following early cardiac surgery. Cardiol. Young-. 22, 574–582 (2012).

    Article  PubMed  Google Scholar 

  8. Turner, T. et al. Language abilities in preschool children with critical CHD: a systematic review. Cardiol. Young 1–11 https://doi.org/10.1017/S1047951122001330 (2022).

  9. Bolduc, M.-E. et al. Motor impairment in children with congenital heart defects: a systematic review. Pediatrics 146, e20200083 (2020).

    Article  PubMed  Google Scholar 

  10. Verrall, C. E. et al. Cognitive functioning and psychosocial outcomes in adults with complex congenital heart disease: a cross-sectional pilot study. Pediatr. Cardiol. 45, 529–543 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Panigrahy, A. et al. Relationship of white matter network topology and cognitive outcome in adolescents with d-transposition of the great arteries. NeuroImage Clin. 7, 438–448 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Westhoff-Bleck, M. et al. Mental disorders in adults with congenital heart disease: Unmet needs and impact on quality of life. J. Affect. Disord. 204, 180–186 (2016).

    Article  PubMed  Google Scholar 

  13. Kovacs, A. H. et al. Depression and anxiety in adult congenital heart disease: predictors and prevalence. Int. J. Cardiol. 137, 158–164 (2009).

    Article  PubMed  Google Scholar 

  14. Birca, A. et al. Interplay of brain structure and function in neonatal congenital heart disease. Ann. Clin. Transl. Neurol. 3, 708–722 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Latal, B. et al. Postoperative amplitude-integrated electroencephalography predicts four-year neurodevelopmental outcome in children with complex congenital heart disease. J. Pediatr. 178, 55–60.e1 (2016).

    Article  PubMed  Google Scholar 

  16. Gunn, J. K. et al. Amplitude-integrated electroencephalography and brain injury in infants undergoing Norwood-type operations. Ann. Thorac. Surg. 93, 170–176 (2012).

    Article  PubMed  Google Scholar 

  17. Sprong, M. C. A. et al. Early determinants of adverse motor outcomes in preschool children with a critical congenital heart defect. J. Clin. Med. 11, 5464 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  18. Gessler, P., Schmitt, B., Prètre, R. & Latal, B. Inflammatory response and neurodevelopmental outcome after open-heart surgery in children. Pediatr. Cardiol. 30, 301–305 (2009).

    Article  PubMed  Google Scholar 

  19. International Cardiac Collaborative on Neurodevelopment (ICCON) Investigators Impact of operative and postoperative factors on neurodevelopmental outcomes after cardiac operations. Ann. Thorac. Surg. 102, 843–849 (2016).

    Article  Google Scholar 

  20. Hövels-Gürich, H. H. Factors influencing neurodevelopment after cardiac surgery during infancy. Front. Pediatr. 4, 137 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  21. Verfaillie, C. J. & Delanghe, J. R. Hemolysis correction factor in the measurement of serum neuron-specific enolase. Clin. Chem. Lab. Med. 48, 891–892 (2010).

    Article  PubMed  CAS  Google Scholar 

  22. Gayger-Dias, V. et al. How S100B crosses brain barriers and why it is considered a peripheral marker of brain injury. Exp. Biol. Med. Maywood NJ 248, 2109–2119 (2023).

    CAS  Google Scholar 

  23. Fink, E. L. et al. Serum biomarkers of brain injury to classify outcome after pediatric cardiac arrest*. Crit. Care Med. 42, 664 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Hu, J. et al. NSE and S100β as serum alarmins in predicting neurological outcomes after cardiac arrest. Sci. Rep. 14, 25539 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Jalali, R. et al. Predicting short- and long-term functional outcomes based on serum s100b protein levels in patients with ischemic stroke. J. Pers. Med. 14, 80 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  26. Qu, Y. et al. The association between serum S100β levels and prognosis in acute stroke patients after intravenous thrombolysis: a multicenter prospective cohort study. BMC Med. 22, 304 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Zarei, H., Roshdi Dizaji, S., Toloui, A., Yousefifard, M. & Esmaeili, A. Diagnostic and prognostic values of S100B versus neuron specific enolase for traumatic brain injury; a systematic review and meta-analysis. Arch. Acad. Emerg. Med. 12, e29 (2024).

    PubMed  PubMed Central  Google Scholar 

  28. Trnka, S. et al. S100B protein as a biomarker and predictor in traumatic brain injury. Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czechoslov. 168, 288–294 (2024).

    Article  Google Scholar 

  29. Bersani, I. et al. Early predictors of abnormal MRI patterns in asphyxiated infants: S100B protein urine levels. Clin. Chem. Lab. Med. 60, 1745–1752 (2022).

    Article  PubMed  CAS  Google Scholar 

  30. Huang, H.-Z., Hu, X.-F., Wen, X.-H. & Yang, L.-Q. Serum neuron-specific enolase, magnetic resonance imaging, and electrophysiology for predicting neurodevelopmental outcomes of neonates with hypoxic-ischemic encephalopathy: a prospective study. BMC Pediatr. 22, 290 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Marino, B. S. et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation 126, 1143–1172 (2012).

    Article  PubMed  Google Scholar 

  32. Lenoir, M. et al. Impact of cardiac surgical timing on the neurodevelopmental outcomes of newborns with Complex congenital heart disease (CHD). Front. Pediatr. 11, 1003585 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  33. Clancy, R. R. et al. Preoperative risk-of-death prediction model in heart surgery with deep hypothermic circulatory arrest in the neonate. J. Thorac. Cardiovasc. Surg. 119, 347–357 (2000).

    Article  PubMed  CAS  Google Scholar 

  34. Jenkins, K. J. et al. Consensus-based method for risk adjustment for surgery for congenital heart disease. J. Thorac. Cardiovasc. Surg. 123, 110–118 (2002).

    Article  PubMed  Google Scholar 

  35. Schlapbach, L. J. et al. International consensus criteria for pediatric sepsis and septic shock. JAMA 331, 665–674 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  36. Centers for Disease Control and Prevention. Pneumonia (Ventilator-Associated [VAP] and Non-Ventilator-Associated Pneumonia [PNEU]) Event. https://www.cdc.gov/nhsn/pdfs/pscmanual/6pscvapcurrent.pdf (2025).

  37. Centers for Disease Control and Prevention. Urinary Tract Infection (Catheter-Associated [CAUTI] and Non-Catheter-Associated [UTI]) Events. https://www.cdc.gov/nhsn/pdfs/pscmanual/7psccauticurrent.pdf (2025).

  38. Centers for Disease Control and Prevention. CDC/NHSN Surveillance Definitions for Specific Types of Infections. https://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf (2025).

  39. Smit, L. H. M., Korse, C. M. & Bonfrer, J. M. G. Comparison of four different assays for determination of serum S-100B. Int. J. Biol. Markers 20, 34–42 (2005).

    Article  PubMed  CAS  Google Scholar 

  40. Stern, P. et al. Performance characteristics of seven neuron-specific enolase assays. Tumour Biol. J. Int. Soc. Oncodev. Biol. Med. 28, 84–92 (2007).

    Article  CAS  Google Scholar 

  41. McCarthy, A. L. et al. Scoring system for periventricular leukomalacia in infants with congenital heart disease. Pediatr. Res. 78, 304–309 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  42. Dimitropoulos, A. et al. Brain injury and development in newborns with critical congenital heart disease. Neurology 81, 241–248 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  43. Papile, L. A., Burstein, J., Burstein, R. & Koffler, H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J. Pediatr. 92, 529–534 (1978).

    Article  PubMed  CAS  Google Scholar 

  44. Greenberg, S. M. et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 8, 165–174 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  45. Barkovich, A. J. et al. MR imaging, MR spectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am. J. Neuroradiol. 27, 533–547 (2006).

    PubMed  PubMed Central  CAS  Google Scholar 

  46. Rutherford, M. A. et al. Abnormal magnetic resonance signal in the internal capsule predicts poor neurodevelopmental outcome in infants with hypoxic-ischemic encephalopathy. Pediatrics 102, 323–328 (1998).

    Article  PubMed  CAS  Google Scholar 

  47. Piper, M. C., Pinnell, L. E., Darrah, J., Maguire, T. & Byrne, P. J. Construction and validation of the Alberta Infant Motor Scale (AIMS). Can. J. Public Health Rev. Can. Sante Publique 83(Suppl 2), S46–50 (1992).

    Google Scholar 

  48. Fourdain, S. et al. Gross motor development of children with congenital heart disease receiving early systematic surveillance and individualized intervention: brief report. Dev. Neurorehabilitation 24, 56–62 (2021).

    Article  Google Scholar 

  49. Bouvier, D. et al. Reference ranges for serum S100B protein during the first three years of life. Clin. Biochem. 44, 927–929 (2011).

    Article  PubMed  CAS  Google Scholar 

  50. Abbasoglu, A. et al. Serum neuron-specific enolase levels in preterm and term newborns and in infants 1–3 months of age. Pediatr. Neonatol. 56, 114–119 (2015).

    Article  PubMed  Google Scholar 

  51. Mazarico, E. et al. Neural injury markers in intrauterine growth restriction and their relation to perinatal outcomes. Pediatr. Res. 82, 452–457 (2017).

    Article  PubMed  CAS  Google Scholar 

  52. Vaughan, T. et al. Can perioperative electroencephalogram and adverse hemodynamic events predict neurodevelopmental outcomes in infants with congenital heart disease?. J. Thorac. Cardiovasc. Surg. 168, 342–352.e7 (2024).

    Article  PubMed  Google Scholar 

  53. Licht, D. J. et al. Brain maturation is delayed in infants with complex congenital heart defects. J. Thorac. Cardiovasc. Surg. 137, 529–536 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  54. Hottinger, S. J. et al. Postoperative improvement of brain maturation in infants with congenital heart disease. Semin. Thorac. Cardiovasc. Surg. 34, 251–259 (2022).

    Article  PubMed  Google Scholar 

  55. Liu, Y., Xu, Y., Li, D., Shi, Y. & Ye, M. Comparison of S100B and NSE between cardiac surgery and interventional therapy for children. Pediatr. Cardiol. 30, 893–897 (2009).

    Article  PubMed  Google Scholar 

  56. Gunn, J. K. et al. Perioperative risk factors for impaired neurodevelopment after cardiac surgery in early infancy. Arch. Dis. Child. 101, 1010–1016 (2016).

    Article  PubMed  Google Scholar 

  57. Peyvandi, S. et al. Declining incidence of postoperative neonatal brain injury in congenital heart disease. J. Am. Coll. Cardiol. 81, 253–266 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  58. Peyvandi, S. & Rollins, C. Fetal brain development in congenital heart disease. Can. J. Cardiol. 39, 115–122 (2023).

    PubMed  Google Scholar 

  59. Sadhwani, A. et al. Fetal brain volume predicts neurodevelopment in congenital heart disease. Circulation 145, 1108–1119 (2022).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  60. Xu, Z. et al. Association between cerebral microbleeds and neurological outcomes in patients who underwent extracorporeal membrane oxygenation. J. Am. Heart Assoc. 13, e037029 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  61. Andersen, K. N. et al. Cerebral microhemorrhages in children with congenital heart disease: prevalence, risk factors, and association with neurodevelopmental outcomes. J. Am. Heart Assoc. 14, e035359 (2025).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  62. Win, K. N., Wang, S. & Undar, A. Microemboli generation, detection and characterization during CPB procedures in neonates, infants, and small children. ASAIO J. Am. Soc. Artif. Intern. Organs 1992 54, 486–490 (2008).

    Google Scholar 

  63. Dubois, M., Scott, D. F. & Savege, T. M. Assessment of recovery from short anaesthesia using the cerebral function monitor. Br. J. Anaesth. 50, 825–832 (1978).

    Article  PubMed  CAS  Google Scholar 

  64. Ortinau, C. M. et al. Early-emerging sulcal patterns are atypical in fetuses with congenital heart disease. Cereb. Cortex N. Y. NY 29, 3605–3616 (2019).

    Article  Google Scholar 

  65. Cromb, D. et al. Individualized cortical gyrification in neonates with congenital heart disease. Brain Commun. 6, fcae356 (2024).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  66. von Rhein, M. et al. Severe congenital heart defects are associated with global reduction of neonatal brain volumes. J. Pediatr. 167, 1259–1263.e1 (2015).

    Article  Google Scholar 

  67. Limperopoulos, C. et al. Neurodevelopmental status of newborns and infants with congenital heart defects before and after open heart surgery. J. Pediatr. 137, 638–645 (2000).

    Article  PubMed  CAS  Google Scholar 

  68. Cossart, R. & Garel, S. Step by step: cells with multiple functions in cortical circuit assembly. Nat. Rev. Neurosci. 23, 395–410 (2022).

    Article  PubMed  CAS  Google Scholar 

  69. Dagenais, L. et al. Superior performance in prone in infants with congenital heart disease predicts an earlier onset of walking. J. Child Neurol. 33, 894–900 (2018).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to all patients and their families who participated in this study. Disclosure of conflict of interest: None of the authors has any conflict of interest to disclose.

Funding

This study was supported by a Young Investigator Grant (AORC Jeune Chercheur) awarded by the GIRCI Méditerranée.

Author information

Authors and Affiliations

Authors

Contributions

B.D. conceived the study. TB, WR, LD, NB, and S.D collected and curated the data. NB and SD performed the statistical analyses. NB, SD and BD interpreted the results. B.D., ML, NB, SD drafted the manuscript with input from all authors. All authors critically revised the manuscript and approved the final version.

Corresponding author

Correspondence to Béatrice Desnous.

Ethics declarations

Competing interests

The authors declare no competing interests.

Consent to participate

Written informed consent was obtained from the parents or legal guardians of all participants prior to inclusion in the study.

Ethical approval

We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boutalbi, N., Dahan, S., Rozalen, W. et al. Early motor outcomes in infants with complex congenital heart disease: the predictive role of NSE and S100B. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04437-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41390-025-04437-8

Search

Quick links